Yiqi Yangyin Huoxue Method in Treating Idiopathic Pulmonary Fibrosis

Autor: Min Zhou et al

Journal: Evidence-Based Complementary and Alternative Medicine Volume 2020, Article ID 8391854, englisch

Objective. Idiopathic pulmonary fibrosis (IPF) is a common respiratory disease that can lead to respiratory failure in severe condition. Despite notable advances in its treatment, some patients show poor effect when treated with conventional western medicine (CWM). Traditional Chinese medicine with the Yiqi Yangyin Huoxue method (YQYYHXM) has been reported to be positive for IPF. In order to explore the effectiveness and safety of YQYYHXM in the treatment of IPF, we performed this meta-analysis.

Method. We searched six databases including Embase, Cochrane, PubMed, CNKI, Wan Fang, and VIP database from their inception to June 1, 2019, and then selected eight studies. Two reviewers independently conducted methodological evaluation and data analysis by the software RevMan 5.3.3 and Stata 12.0.

Results. The meta-analysis revealed that when YQYYHXM was adopted in combination with CWM, cough, chest pain, and shortness of breath of IPF patients improved significantly. After treatment with YQYYHXM combined with CWM, the SGRQ of IPF patients substantially enhanced. YQYYHXM also has positive effect on 6MWD and TLC, but the improvement on FVC was not obvious. In addition, YQYYHXM has no significance in improving PaO2. All the adverse events were reported in the control group.

Conclusion. YQYYHXM is more effective and safe as adjunctive treatment for patients with IPF. However, in the future, long-term, large-scale, and high-quality trials will be required to provide more convincing evidence of YQYYHXM due to some limitations of this review.

Andere Benutzer haben sich neben diesem auch noch folgende Artikel angesehen:

Die Behandlung von reaktiver Arthritis mit Chinesischer Medizin
Shen Pi’an (Übers. A. Fatrai); 2020

Effectiveness and safety of traditional Chinese medical therapy for cancer-related fatigue
Yueyang Zhao et al; 2020

Treatment of Masked Hypertension with a Chinese Herbal Formula
Dong-Yan Zhang et al; 2020


Vorheriger Artikel


Nächster Artikel

Link zum Journal